1. Department of Neurology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang Province, China.
2. School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang Province, China.
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022 Dec 25;51(6):738-749. doi: 10.3724/zdxbyxb-2022-0180.
Fibroblast growth factors (FGF) are a group of structurally related polypeptides which constitute an elaborate signaling system with their receptors. Evidence accumulated in the years suggests that the FGF family plays a key role in the repair of central nervous system injury. The main protective mechanisms include activating the expression of PI3K-Akt, peroxisome proliferator-activated receptor (PPARγ) and other signals; inhibiting NF-κB-mediated inflammatory response, oxidative stress and apoptosis; regulating neuronal differentiation and neuronal excitability as well as participating in protection of neurovascular units and nerve function repair. This paper comprehensively summarizes the latest research progress in FGF signaling related to diseases of the central nervous system such as cerebral infarction, cerebral hemorrhage, traumatic brain injury, Alzheimer's disease, Parkinson's disease, epilepsy and depression, aiming to provide scientific basis and reference for the development of innovative FGF drugs for the prevention and treatment of neurological diseases.
成纤维细胞生长因子(FGF)是一组结构相关的多肽,它们与其受体构成了一个复杂的信号系统。多年来积累的证据表明,FGF 家族在中枢神经系统损伤的修复中起着关键作用。主要的保护机制包括激活 PI3K-Akt、过氧化物酶体增殖物激活受体(PPARγ)和其他信号的表达;抑制 NF-κB 介导的炎症反应、氧化应激和细胞凋亡;调节神经元分化和神经元兴奋性,以及参与保护神经血管单元和神经功能修复。本文综合总结了 FGF 信号与脑梗死、脑出血、创伤性脑损伤、阿尔茨海默病、帕金森病、癫痫和抑郁症等中枢神经系统疾病相关的最新研究进展,旨在为开发用于预防和治疗神经疾病的创新性 FGF 药物提供科学依据和参考。